PMID- 18721325
OWN - NLM
STAT- MEDLINE
DCOM- 20080924
LR  - 20240511
IS  - 1365-2249 (Electronic)
IS  - 0009-9104 (Print)
IS  - 0009-9104 (Linking)
VI  - 153 Suppl 1
IP  - Suppl 1
DP  - 2008 Sep
TI  - Allergy and the nose.
PG  - 22-6
LID - 10.1111/j.1365-2249.2008.03717.x [doi]
AB  - Allergic rhinitis (AR) is the most common immunological disorder and is 
      characterized by an immunoglobulin E (IgE)-mediated inflammation induced by the 
      allergen exposure. This review will consider some issues concerning 
      pathophysiological aspects of AR: impact on asthma, response to decongestion, 
      link with infections, response to specific immunotherapy, relationship with 
      adiposity, effects on quality of life (QoL) and allergic inflammation. AR, even 
      though not a serious illness, may be a clinically relevant disorder as it may 
      present numerous complications and affect QoL, as reported in this review. 
      Therefore, the management of AR patients should be rigorously careful and 
      multi-disciplinary.
FAU - Ciprandi, G
AU  - Ciprandi G
AD  - Semeiotica e Metodologia Medica I, Department of Internal Medicine, University of 
      Genoa, Genoa, Italy. gio.cip@libero.it
FAU - Passalacqua, G
AU  - Passalacqua G
LA  - eng
PT  - Journal Article
PT  - Review
PL  - England
TA  - Clin Exp Immunol
JT  - Clinical and experimental immunology
JID - 0057202
RN  - 0 (Allergens)
RN  - 37341-29-0 (Immunoglobulin E)
SB  - IM
MH  - Allergens/*immunology
MH  - Animals
MH  - Eosinophilia/immunology
MH  - Humans
MH  - Hypersensitivity/*immunology
MH  - Immunoglobulin E/immunology
MH  - Nasal Mucosa/*immunology
MH  - Rhinitis/*immunology
MH  - Th2 Cells/immunology
PMC - PMC2515355
EDAT- 2008/09/06 09:00
MHDA- 2008/09/25 09:00
PMCR- 2009/09/01
CRDT- 2008/09/06 09:00
PHST- 2008/09/06 09:00 [pubmed]
PHST- 2008/09/25 09:00 [medline]
PHST- 2008/09/06 09:00 [entrez]
PHST- 2009/09/01 00:00 [pmc-release]
AID - CEI3717 [pii]
AID - 10.1111/j.1365-2249.2008.03717.x [doi]
PST - ppublish
SO  - Clin Exp Immunol. 2008 Sep;153 Suppl 1(Suppl 1):22-6. doi: 
      10.1111/j.1365-2249.2008.03717.x.